UF Urology Receives $2.5M for Bladder Research
UF researchers Sergei Kusmartsev, Ph.D., and William Donelan, Ph.D., along with Padraic O’Malley, M.Sc., M.D., FRCSC, recognized in Doctor Gator, College of Medicine News. …
UF researchers Sergei Kusmartsev, Ph.D., and William Donelan, Ph.D., along with Padraic O’Malley, M.Sc., M.D., FRCSC, recognized in Doctor Gator, College of Medicine News. …
We are pleased to announce that William Donelan, PhD, and his mentor Sergei Kusmartsev, PhD, have received an American Cancer Society Institutional Research Grant to develop novel antibody-drug conjugates for the treatment of bladder cancer.
“The new treatment would combine this antibody with a very potent form of chemotherapy,” said Paul Crispen, MD, an associate professor in the UF Department of Urology. “This antibody drug conjugate could potentially deliver the chemotherapy selectively to areas of cancer to increase efficacy and limit toxicity.”
Plain talk for men and their loved ones about elevated PSAs, biopsies, active surveillance and treatment for the leading cancer diagnosis in men. Discover the difference that a multidisciplinary urologic oncology program can make.
Bladder cancer patients, survivors and their families and friends are welcome to attend. Participants will learn from and support others who have been affected by bladder cancer, while sharing resources and information.
Join us Thursday, October 3rd at 5:30 pm!…
Click here to register your attendance …